← FDA Drug Approvals (Drugs@FDA)

EMSAM

NDA · New Drug Application · Sponsor: SOMERSET · Approved 2006-02-27

Drug application

FDA Application #

NDA021708

Application type

New Drug Application

Brand name

EMSAM

Generic name

Selegiline

Active ingredients

SELEGILINE

Dosage form

SYSTEM

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

SOMERSET

First approval

2006-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown